NRP 730, Week 5 Assignment Discussion Essay
Ethical and Legal Aspects of Practice Change
Participants of the Proposed DNP practice change Project
For the DNP practice change project, I will enlist children between the ages of 8 and 12 who have already been diagnosed with ADHD and are undergoing treatment at the pediatric outpatient mental health clinic where I plan to carry out this project.
Participant Benefits and Risks
Incorporating EndeavorRx into the treatment plans of children with ADHD offers several potential benefits, such as enhancing attention and cognitive functioning. These improvements can positively impact academic performance and interpersonal relationships, ultimately leading to an improved quality of life for these children (Sibley et al., 2023). Furthermore, this intervention addresses specific cognitive needs that current standard therapies may not adequately address. However, it is essential to consider the potential risks associated with this intervention. One concern is unequal access to technology since EndeavorRx requires an internet connection and suitable devices (Rahaman, 2023). This could create disparities in who can benefit from game-based therapy. Maintaining long-term engagement may also be challenging, potentially limiting its effectiveness over time. Furthermore, it is worth noting that the short duration of specific projects or discrepancies in reporting from parents or caregivers may introduce possible data inaccuracies when evaluating the outcomes of using EndeavorRx.
Measures to Protect Participants’ Human Rights
To safeguard the human rights of the participants, the subsequent actions will be implemented:
- Informed Consent: Before their child’s involvement in the study, parents or guardians will receive detailed information about the project, including its purpose and how their child will be involved. Therefore, parents or guardians must provide informed consent before children can participate.
- Respecting Autonomy: Through their guardians, participants will be informed that their involvement is voluntary, and they can discontinue participation at any point without facing any negative consequences regarding their regular care.
- Privacy and Confidentiality: All participant information will remain confidential and solely used for research (McIltrot et al., 2022). Any identifiable information will be anonymized during data analysis to protect participant privacy.
- Equitable Access: We are committed to ensuring all individuals have equal access to the intervention (Meinen, 2023). This includes collaborating with local organizations or schools to provide necessary resources (such as devices) or assist with internet access in cases where technological limitations may exist.
- Beneficence and non-maleficence: Continuous monitoring of potential benefits and risks will be carried out throughout the study. If unforeseen risks or harms are identified, necessary adjustments will be promptly implemented to ensure participant safety, even if it means terminating the
McIltrot, K., Busch, D. W., Van Graafeiland, B., Stashinko, E., Abshire, M., Daniels, M., Pandian, V., Panchalingam, S., Himmelfarb, C. R., & D’ Aoust, R. (2022). Establishing the doctor of nursing practice project ethical review process to improve standardization, efficiency, and timeliness. Nursing Outlook, 70(4), 616–624. https://doi.org/10.1016/j.outlook.2022.03.002
Meinen, L. E. (2023). Share the experience, do not take it: Toward attunement with neurodiversity in video games. Games and Culture, 155541202211495. https://doi.org/10.1177/15554120221149538
Rahaman, T. (2023). Empowering patients one app at a time: An introduction to digital therapeutics. Medical Reference Services Quarterly, 42(3), 301–307. https://doi.org/10.1080/02763869.2023.2225352
Sibley, M. H., Bruton, A. M., Zhao, X., Johnstone, J. M., Mitchell, J., Hatsu, I., Arnold, L. E., Basu, H. H., Levy, L., Vyas, P., Macphee, F., Gonzalez, E. S., Kelley, M., Jusko, M. L., Bolden, C. R., Zulauf-McCurdy, C., Manzano, M., & Torres, G. (2023). Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. The Lancet Child & Adolescent Health. https://doi.org/10.1016/S2352-4642(22)00381-9
The Ethical and Legal Aspects of Practice Change
The purpose of this assignment is to examine the ethical responsibilities of a DNP-prepared nurse when implementing practice change.
Reflect on your readings this week and respond to the following:
Identify the participants of your proposed DNP practice change project as stated in your PICOT question.
Examine the benefits and risks for the participants of your DNP practice change project.
Detail the measures you will take to protect their human rights.
Please click on the following link to review the DNP Discussion Guidelines on the Student Resource Center program page:
Link (webpage): DNP Discussion GuidelinesLinks to an external site.
This discussion enables the student to meet the following program outcomes:
Integrates scientific underpinnings into everyday clinical practice. (POs 3, 5)
Applies organizational and system leadership skills to affect systemic changes in corporate culture and to promote continuous improvement in clinical outcomes. (PO 6)
Uses analytic methods to translate critically appraised research and other evidence into clinical scholarship for innovative practice improvements. (POs 3, 5)
Appraises current information systems and technologies to improve health care. (POs 6, 7)
Analyzes health care policies to advocate for equitable health care and social justice to all populations and those at risk due to social determinants of health. (POs 2, 9)
Creates a supportive organizational culture for flourishing collaborative teams to facilitate clinical disease prevention and promote population health at all system levels. (PO 8)
Leads others in professional identity, advanced clinical judgment, systems thinking, resilience, and accountability in selecting, implementing, and evaluating clinical care. (POs 1, 4)
This discussion enables the student to meet the following course outcomes:
Prioritize and apply ethical considerations and theories relevant to translation science. (PCs 1, 3, 8; POs 3, 4, 5)
Apply clinical scholarship methodologies for designing, developing, implementing, and evaluating quality improvements and the translation of evidence-based practice, to improve healthcare outcomes at the micro, meso, or macrosystem level. (PCs 1, 3, 5; POs 3, 5, 9)